Age-specific analysis revealed a higher MGUS risk in the 20-39 age group compared to the 40-64 and ≥65 age groups, with a nearly significant interaction P value of 0.053.
← all excerpts
Metabolic syndrome and risk of monoclonal gammopathy of undetermined significance: a large Korean cohort study.
1
—
—